Metomidine hydrochloride

‌Brinzolamide Intermediate (CAS 160982-10-5) | High-Quality API Synthesis Building Block‌
‌Google Search Keywords‌: Brinzolamide Intermediate, CAS 160982-10-5, Carbonic Anhydrase Inhibitor Intermediate, API Synthesis, Pharmaceutical Intermediates

🔬 ‌Product Overview‌
Brinzolamide Intermediate (CAS 160982-10-5) is a key chemical building block in the synthesis of Brinzolamide, a carbonic anhydrase inhibitor used to treat glaucoma and ocular hypertension. This intermediate ensures efficient and scalable production of high-purity active pharmaceutical ingredients (APIs).
‌Primary Function‌: Critical precursor in Brinzolamide API manufacturing.
‌Applications‌: Pharmaceutical synthesis, generic drug development, process optimization.

✅ ‌Key Advantages‌
⭐ ‌High Yield & Purity‌

• Purity ≥99% (HPLC), optimized for seamless API synthesis.

⚡ ‌Process Efficiency‌

• Reduces synthesis steps, enhancing cost-effectiveness and production timelines.

🌡️ ‌Stability‌

• Stable under standard storage conditions, ensuring consistent performance.

📋 ‌Applications‌

1. ‌API Manufacturing‌: Core component in Brinzolamide production.

2. ‌Generic Drug Development‌: Supports cost-effective alternatives to branded medications.

3. ‌Process Chemistry‌: Used in route scouting and optimization studies.

🏅 ‌Quality Certifications‌

• Rigorously tested via ‌HPLC, GC, and NMR‌ (compliant with ICH Q7 and USP/EP standards).

• Batch-specific Certificate of Analysis (CoA) ensures traceability and compliance.

🌐 ‌Market Trends‌
The global pharmaceutical intermediates market is expected to grow at ‌6.2% CAGR (2023-2030)‌, fueled by rising demand for glaucoma therapies and generic APIs. Brinzolamide intermediates are pivotal in meeting the needs of expanding ophthalmic drug manufacturing.

🔍 ‌Why Choose Us?‌

• Custom synthesis and bulk order capabilities.

• Fast global delivery with cold-chain support.

• Expert technical guidance for API development.